HempNewsBreaks – EVIO, Inc. (EVIO) Opens Fifth Testing Location in Eastern Oregon

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced the opening of its fifth testing location in eastern Oregon. “We are excited to announce our new location in La Grande, OR,” William Waldrop, CEO of EVIO, stated in the news release. “Oregon recently passed OAR 603-048 which requires all industrial hemp and hemp derived manufactured products to be tested by an accredited testing lab prior to being made available for sale. Our new location, is the only lab in eastern Oregon and is strategically located near a significant number of Oregon’s 233 licensed hemp growers and 173 licensed manufacturers and distributors… We feel these new rules can add an additional 40% to the potential Oregon testing market in the short term and products derived by CBD can eventually outpace the existing medical and recreational cannabis markets.”

To view the full press release, visit http://cnw.fm/YgYk6

About EVIO, Inc.

EVIO, Inc. is an Oregon-based life sciences company that provides analytical testing services, management advisory services and scientific research to the legal cannabis and hemp industries. The Company’s EVIO Labs division operates state-of-the-art facilities and offers accredited testing methodologies to ensure the safety and quality of the nation’s cannabis supply. Learn more at www.EvioLabs.com or the Company can be reached directly @ 1-888-544-EVIO.

More from CannabisNewsBreaks

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 

Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…

2 months ago

HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…

4 months ago

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…

4 months ago

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call…

5 months ago

HempNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70…

6 months ago

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that…

7 months ago